Skip to main content
SpringerLink
Log in

Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Cancer and its treatment are recognized risk factors for VTE. Compliance rate with published VTE prophylaxis guidelines is low. Decision on when to offer prophylaxis for hospitalized cancer patients is difficult to make. This paper describes current clinical practice in offering VTE prophylaxis to hospitalized cancer patients. Prophylaxis rate and rate of VTE will be correlated with the risk level. We prospectively followed all consecutive adult cancer patients admitted to medical units over a 5-month period. Caprini risk assessment model, with some modifications, was utilized to determine risk of VTE. Six hundred and six patients (51% males, median age 52 years, range 18–91) were included. Reasons for admission included infections (25%), chemotherapy (22%) and palliative care (10%). In addition to cancer, the most frequently encountered risk factors for VTE were: Immobilization (35%), age > 60 years (31%) and body mass index > 30 in (20%). Patients were grouped according to their total risk score: low (9%), moderate (44%) and high risk (47%). VTE prophylaxis rate was 55.1% for the whole study group. Following discharge, patients were followed for 60 days. The incidence of VTE was 3.4% in the moderate and 4.2% in the high risk groups, while none in the low risk group developed VTE. Many additional risk factors for VTE are usually encountered in hospitalized cancer patients. Cancer alone may not be an enough reason for VTE prophylaxis. Risk assessment model able to stratify patients into different risk categories will simplify decision making and enhance VTE prophylaxis rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kniffin WD, Baron JA, Barret J, Bikmeyer JD, Anderson FA (1994) The epidemiology of pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 154:861–866

    Article  PubMed  Google Scholar 

  2. Belch JJ, Lowe GDO, Ward AG, Forbes CD, Prentice CRM (1981) Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 26:115–117

    CAS  PubMed  Google Scholar 

  3. Heit JA, Silverstein MD, Mohr DN et al (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160:809–815

    Article  CAS  PubMed  Google Scholar 

  4. Heit JA, O’Fallon WM, Petterson TM et al (2002) Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162:1245–1248

    Article  PubMed  Google Scholar 

  5. Thodiyil PA, Kakkar AK (2002) Variation in relative risk of venous thromboembolism in different cancers. Thromb Haemost 87:1076–1077

    CAS  PubMed  Google Scholar 

  6. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M et al (1996) The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125:1–7

    CAS  PubMed  Google Scholar 

  7. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI, Schwartz JS, Thompson BT, Popovich J Jr, Hobbins TE et al (1992) The clinical course of pulmonary embolism. N Engl J Med 326:1240–1245

    Article  CAS  PubMed  Google Scholar 

  8. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350:2257–2264

    Article  CAS  PubMed  Google Scholar 

  9. Sørensen HT, Mellemkj’r L, Olsen JH et al (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846–1850

    Article  PubMed  Google Scholar 

  10. Caprini J, Arcelus J, Reyna J (2001) Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 38:12–19

    Article  CAS  PubMed  Google Scholar 

  11. Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AG, Glezer S, Thabane L, Sebaldt RJ, CURVE Study Investigators (2007) Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 119:145–155

    Article  CAS  PubMed  Google Scholar 

  12. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr, ENDORSE Investigators (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371:387–394

    Article  PubMed  Google Scholar 

  13. Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, Spyropoulos AC, Merli GJ, Zotz RB, Bergmann JF, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA, Fitzgerald G, Anderson FA Jr, IMPROVE Investigators (2007) Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism. Chest 132:936–945

    Article  PubMed  Google Scholar 

  14. Ageno W, Squizzato A, Ambrosini F et al (2002) Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 87:746–750

    PubMed  Google Scholar 

  15. Chopard P, Dorffler-Melly J, Hess U et al (2005) Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. J Intern Med 257:352–357

    Article  CAS  PubMed  Google Scholar 

  16. Monreal M, Kakkar AK, Caprini JA, Barba R, Uresandi F, Valle R, Suarez C, Otero R, RIETE Investigators (2004) The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost 2:1889–1891

    Article  Google Scholar 

  17. Motykie G, Zebala L, Caprini J, Lee C, Arcelus J, Reyna J, Cohen E, Courtney T, Sullivan L (2000) A guide to venous thromboembolism risk factor assessment. J Thromb Thrombolysis 9:253–262

    Article  CAS  PubMed  Google Scholar 

  18. Sallah S, Wan JY, Nguyen NP (2002) Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 87:575–579

    CAS  PubMed  Google Scholar 

  19. Chew HK, Wun T, Harvey D et al (2006) Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166:458–464

    Article  PubMed  Google Scholar 

  20. Marras LC, Geerts WH, Perry JR (2000) The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 89:640–646

    Article  CAS  PubMed  Google Scholar 

  21. Gerber DE, Grossman SA, Streiff MB (2006) Management of venous thromboembolism in patients with primary and metastatic brain tumors. J Clin Oncol 24:1310–1318

    Article  CAS  PubMed  Google Scholar 

  22. Andtbacka RH, Babiera G, Singletary SE et al (2006) Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg 243:96–101

    Article  PubMed  Google Scholar 

  23. Chew HK, Wun T, Harvey DJ et al (2007) Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol 25:70–76

    Article  PubMed  Google Scholar 

  24. Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and risk of venous thrombosis. JAMA 293:715–722

    Article  CAS  PubMed  Google Scholar 

  25. Haddad TF, Greeno EW (2006) Chemotherapy-induced thrombosis. Thromb Res 118:547–666

    Article  Google Scholar 

  26. Geerts W, Bergqvist D, Pineo G et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133:381–453

    Article  Google Scholar 

  27. American Society of Clinical Oncology Guideline (2007) Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25:5490–5505

    Article  Google Scholar 

  28. NCCN, clinical practice guidelines in oncology (2008) Venous thromboembolic disease. J Natl Compr Canc Netw 6:716–753

    Google Scholar 

  29. Hull RD, Schellong SM, Tapson VF et al (2006) Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study. J Thromb Thrombolysis 22:31–38

    Article  CAS  PubMed  Google Scholar 

  30. Bosson JL, Pouchain D, Bergmann JF, for the ETAPE Study Group (2006) A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices. J Intern Med 260:168–176

    Article  PubMed  Google Scholar 

  31. Khorana AA, Kuderer NM, Culakova E et al (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902–4907

    Article  CAS  PubMed  Google Scholar 

  32. Ay C, Simanek R, Vormittag R et al (2008) High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 112:2703–2708

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The authors would like to thank Dr. L. Zaru and Dr. J. Caprini, for their valuable comments in preparing this manuscript and Mr. A. Harb for his help in preparing the illustrations.

Author information

Authors and Affiliations

  1. Division of Hematology and Medical Oncology, Department of Internal Medicine, King Hussein Cancer Center, Queen Rania Al Abdullah Street, P.O. Box: 1269, Amman, 11941, Jordan

    H. N. Abdel-Razeq, S. B. Hijjawi, S. G. Jallad & B. A. Ababneh

Authors
  1. H. N. Abdel-Razeq
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. B. Hijjawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. G. Jallad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. A. Ababneh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. N. Abdel-Razeq.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdel-Razeq, H.N., Hijjawi, S.B., Jallad, S.G. et al. Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience. J Thromb Thrombolysis 30, 286–293 (2010). https://doi.org/10.1007/s11239-010-0445-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-010-0445-9

Keywords

Search

Navigation